MEDP
Medpace Holdings IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$12.36B
P/E Ratio
27.25
EPS
$15.88
Beta
1.19
52W High
$628.92
52W Low
$291.28
50-Day MA
$456.76
200-Day MA
$512.98
Dividend Yield
—
Profit Margin
17.20%
Forward P/E
25.71
PEG Ratio
2.66
About Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company is headquartered in Cincinnati, Ohio.
Fundamentals
| Revenue (TTM) | $2.68B |
| Gross Profit (TTM) | $1.93B |
| EBITDA | $591.01M |
| Operating Margin | 20.00% |
| Return on Equity | 77.20% |
| Return on Assets | 17.50% |
| Revenue/Share (TTM) | $94.44 |
| Book Value | $20.95 |
| Price-to-Book | 20.66 |
| Price-to-Sales (TTM) | 4.62 |
| EV/Revenue | 4.417 |
| EV/EBITDA | 20.02 |
| Quarterly Earnings Growth (YoY) | 16.60% |
| Quarterly Revenue Growth (YoY) | 26.50% |
| Shares Outstanding | $28.56M |
| Float | $23.00M |
| % Insiders | 19.42% |
| % Institutions | 88.84% |
Historical Volatility
HV 10-Day
17.93%
HV 20-Day
22.94%
HV 30-Day
80.15%
HV 60-Day
61.98%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($442.83 target)
1
Strong Buy3
Buy8
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026